These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 9473866)

  • 21. Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study (UKPDS) Group.
    Turner RC; Cull CA; Frighi V; Holman RR
    JAMA; 1999 Jun; 281(21):2005-12. PubMed ID: 10359389
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Achieving further glycemic control in type 2 diabetes mellitus.
    Nichols GA; Glauber HS; Javor K; Brown JB
    West J Med; 2000 Sep; 173(3):175-9. PubMed ID: 10986179
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Metformin added to insulin therapy in poorly controlled type 2 diabetes.
    Hirsch IB
    Diabetes Care; 1999 May; 22(5):854. PubMed ID: 10332695
    [No Abstract]   [Full Text] [Related]  

  • 24. (7) Approaches to glycemic treatment.
    American Diabetes Association
    Diabetes Care; 2015 Jan; 38 Suppl():S41-8. PubMed ID: 25537707
    [No Abstract]   [Full Text] [Related]  

  • 25. Eff ectiveness of Teneligliptin as an Add-on in T2DM Patients not Controlled on Metformin and Glimepiride.
    Kashiv P; Kumar J
    J Assoc Physicians India; 2020 Jan; 68(1):51. PubMed ID: 31979567
    [No Abstract]   [Full Text] [Related]  

  • 26. Diabetes treatment intensification and associated changes in HbA1c and body mass index: a cohort study.
    Roumie CL; Greevy RA; Grijalva CG; Hung AM; Liu X; Griffin MR
    BMC Endocr Disord; 2016 Jun; 16(1):32. PubMed ID: 27255309
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of antihyperglycemic agents added to metformin and a sulfonylurea on glycemic control and weight gain in type 2 diabetes: a network meta-analysis.
    Gross JL; Kramer CK; Leitão CB; Hawkins N; Viana LV; Schaan BD; Pinto LC; Rodrigues TC; Azevedo MJ;
    Ann Intern Med; 2011 May; 154(10):672-9. PubMed ID: 21576535
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term efficacy of sulfonylureas: a United Kingdom Prospective Diabetes Study perspective.
    Holman RR
    Metabolism; 2006 May; 55(5 Suppl 1):S2-5. PubMed ID: 16631806
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Addition of pioglitazone or bedtime insulin to maximal doses of sulfonylurea and metformin in type 2 diabetes patients with poor glucose control: a prospective, randomized trial.
    Aljabri K; Kozak SE; Thompson DM
    Am J Med; 2004 Feb; 116(4):230-5. PubMed ID: 14969650
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Free fatty acid kinetics during long-term treatment with pioglitazone added to sulfonylurea or metformin in Type 2 diabetes.
    Roden M; Mariz S; Brazzale AR; Pacini G
    J Intern Med; 2009 Apr; 265(4):476-87. PubMed ID: 19298459
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Early insulin use in type 2 diabetes: what are the cons?
    Chiasson JL
    Diabetes Care; 2009 Nov; 32 Suppl 2(Suppl 2):S270-4. PubMed ID: 19875563
    [No Abstract]   [Full Text] [Related]  

  • 32. Metformin useful in combination with exogenous insulin.
    Hanuschak LN
    Diabetes Care; 1996 Jun; 19(6):671-2. PubMed ID: 8725873
    [No Abstract]   [Full Text] [Related]  

  • 33. Glycaemic control among patients with type 2 diabetes mellitus in seven European countries: findings from the Real-Life Effectiveness and Care Patterns of Diabetes Management (RECAP-DM) study.
    Alvarez Guisasola F; Mavros P; Nocea G; Alemao E; Alexander CM; Yin D
    Diabetes Obes Metab; 2008 Jun; 10 Suppl 1():8-15. PubMed ID: 18435669
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 10-year follow-up of intensive glucose control in type 2 diabetes.
    Holman RR; Paul SK; Bethel MA; Matthews DR; Neil HA
    N Engl J Med; 2008 Oct; 359(15):1577-89. PubMed ID: 18784090
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Follow-up of intensive glucose control in type 2 diabetes.
    Lund SS; Rossing P; Vaag AA
    N Engl J Med; 2009 Jan; 360(4):416; author reply 418. PubMed ID: 19164195
    [No Abstract]   [Full Text] [Related]  

  • 36. Insulin glargine added to therapy with oral antidiabetic agents improves glycemic control and reduces long-term complications in patients with type 2 diabetes - a simulation with the Diabetes Mellitus Model (DMM).
    Janka HU; Hessel F; Walzer S; Mã Ller E
    Int J Clin Pharmacol Ther; 2007 Dec; 45(12):623-30. PubMed ID: 18184530
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comment on: Nauck MA, Duran S, Kim D et al (2007) A comparison of twice-daily exenatide and biphasic insulin aspart in patients with type 2 diabetes who were suboptimally controlled with sulfonylurea and metformin: a non-inferiority study. Diabetologia 50:259-267.
    Home PD
    Diabetologia; 2007 Jul; 50(7):1561-2; author reply 1563-4. PubMed ID: 17384924
    [No Abstract]   [Full Text] [Related]  

  • 38. The effect of a thiazolidinedione drug, troglitazone, on glycemia in patients with type 2 diabetes mellitus poorly controlled with sulfonylurea and metformin. A multicenter, randomized, double-blind, placebo-controlled trial.
    Yale JF; Valiquett TR; Ghazzi MN; Owens-Grillo JK; Whitcomb RW; Foyt HL
    Ann Intern Med; 2001 May; 134(9 Pt 1):737-45. PubMed ID: 11329231
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Early combination therapy for the treatment of type 2 diabetes mellitus: systematic review and meta-analysis.
    Phung OJ; Sobieraj DM; Engel SS; Rajpathak SN
    Diabetes Obes Metab; 2014 May; 16(5):410-7. PubMed ID: 24205921
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A comparison of acarbose versus metformin as an adjuvant therapy in sulfonylurea-treated NIDDM patients.
    Bayraktar M; Van Thiel DH; Adalar N
    Diabetes Care; 1996 Mar; 19(3):252-4. PubMed ID: 8742572
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.